
MoonLake Immunotherapeutics
MLTXNasdaqCIK 1821586HealthcareFiscal year ends Dec 31
Reports and events: 103 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2609:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-016737 |
| 2023-11-1408:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001821586-23-000022 |
| 2023-11-1408:01 ET | 8-K | 2.02 Results of operations | 0001821586-23-000020 |
| 2023-11-0607:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-036888 |
| 2023-10-1606:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-23-003933 |
| 2023-09-1111:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-075653 |
| 2023-09-0117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-23-073296 |
| 2023-08-1008:17 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001821586-23-000015 |
| 2023-08-1008:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-065274 |
| 2023-06-3016:41 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-23-000934 |
| 2023-06-2916:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-023905 |
| 2023-06-2608:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-023381 |
| 2023-06-0716:31 ET | 8-K | 5.07 Shareholder vote results | 0001213900-23-047184 |
| 2023-05-1916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-23-041556 |
| 2023-05-1116:03 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001821586-23-000012 |
| 2023-04-2616:31 ET | DEF 14A | Proxy statementPeriod 2023-06-07 | 0001140361-23-020595 |
| 2023-04-1909:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-030849 |
| 2023-03-2008:44 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001821586-23-000007 |
| 2023-03-2007:44 ET | 8-K | 2.02 Results of operations | 0001821586-23-000004 |
| 2023-03-1017:07 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-23-019254 |
| 2022-11-1407:55 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001821586-22-000009 |
| 2022-08-1216:04 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001821586-22-000006 |
| 2022-07-2608:43 ET | S-1/A | Registration statement, amended | 0001213900-22-041495 |
| 2022-07-1517:08 ET | S-1/A | Registration statement, amended | 0001213900-22-039695 |
| 2022-06-1716:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-22-033592 |
| 2022-06-0708:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-031476 |
| 2022-05-1616:10 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-22-027102 |
| 2022-05-1616:05 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-027086 |
| 2022-05-0216:10 ET | S-1/A | Registration statement, amended | 0001213900-22-023173 |
| 2022-04-1816:49 ET | SC 13D | Ownership report, active investor | 0000921895-22-001288 |
| 2022-04-1116:40 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-019217 |
| 2022-03-3117:29 ET | 8-K | 5.07 Shareholder vote results | 0001213900-22-016984 |
| 2022-03-2416:49 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-22-014894 |
| 2022-03-1416:16 ET | S-1/A | Registration statement, amended | 0001213900-22-012161 |
| 2022-03-0816:17 ET | S-1/A | Registration statement, amended | 0001213900-22-011107 |
| 2022-02-2516:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-22-009481 |
| 2022-02-1716:07 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-008253 |
| 2022-02-1121:52 ET | S-1 | Registration statement | 0001213900-22-006626 |
| 2021-12-1417:19 ET | 10-Q/A | Quarterly report, amendedPeriod 2021-09-30 | 0001213900-21-065247 |
| 2021-12-1417:18 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001213900-21-065246 |
| 2021-12-0316:04 ET | 8-K | 4.02 Non-reliance on financial statements | 0001213900-21-063323 |
| 2021-11-1216:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-058671 |
| 2021-10-0407:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-051257 |
| 2021-08-1616:03 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-042958 |
| 2021-05-2116:14 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-028399 |
| 2021-05-0316:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-21-024220 |
| 2021-03-3109:59 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-019007 |
| 2020-12-0316:31 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-040763 |
| 2020-10-2817:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-033731 |
| 2020-10-2217:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-032858 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 07:34 ET. Listed shows no prices and gives no investment advice.